Home > Newsletters > FDAnews Drug Daily Bulletin > Senate HELP Committee Confronts State Board Over NECC Pharmacy Classification
FDAnews Drug Daily Bulletin
Oct. 29, 2012 | Vol. 9 No. 212
Senate HELP Committee Confronts State Board Over NECC Pharmacy Classification
The Senate Committee on Health, Education, Labor, & Pensions (HELP) is launching a probe of the compounding crisis, asking the Massachusetts pharmacy registrar to explain why New England Compounding Center (NECC) was allowed to operate as a large-scale drug manufacturer. NECC, the compounder blamed for an outbreak of fungal meningitis, was allowed to maintain its business classification as a pharmacy despite past sterility concerns that led to a 2006 consent decree with the Massachusetts Board of Pharmacy, Sen. Tom Harkin (D-Iowa) and 20 other HELP Committee members said in a Thursday letter to James Coffey, the board’s director.
Drug Industry Daily
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.